<p><i>(</i><i>a</i><i>),</i> Lysis by the IDO5-specific T-cell clone (RBS35) of the HLA-A2<sup>+</sup> breast cancer cell lines CAMA-1 <i>(right)</i> and MDA-MB-231 <i>(left)</i> before and after IFN-γ treatment. <i>(</i><i>b</i><i>)</i>, Histograms showing intracellular IDO expression in CAMA-1 before and after IFN-γ treatment. Data are representative of 3 experiments. Intracellular IDO expression was given by a one-tailed two sampled t-test comparing MFI<sub>IDO</sub> (dark histograms) and MFI<sub>Isotype control</sub> (light histograms), where MFI is the Mean Fluorescence Intensity. The fold of expression was defined as MFI<sub>IDO</sub>/MFI<sub>Isotype control</sub>. <i>Top:</i> CAMA-1 (<i>p</i> = 0.020 and MFI<sub>IDO</sub>/MFI<sub>Iso...
<p>Proliferation of each of 5 individual A549 cell clonal populations before <b>(Panel A and C)</b> ...
Triple-negative breast cancer (TNBC) escape from immune-mediated destruction was associated with imm...
<p>Interfering with the IFNγ pathway in MSCs can partially restore Vδ2+ cell proliferation (A) Compa...
<p><i>(</i><i>a</i><i>)</i>, <i>Left:</i> Lysis of autologous <i>in vitro</i> immatured and matured ...
<p><i>(</i><i>a</i><i>),</i> Lysis of T2-cells pulsed with IDO5 peptide or an irrelevant peptide (th...
<p>(A) Lentiviral-mediated shRNA transduction of MSCs was used to knock down IDO (MSC-IDOi). Quantif...
<p>A549 cells were transfected with control or anti-thymidylate synthase (anti-TS) siRNA, treated wi...
<p>A549 cells were transfected with scrambled, non-targeting control siRNA or anti-thymidylate synth...
<p>PBMC from healthy donors, breast cancer patients, melanoma patients, and renal cell carcinoma pat...
<p>A549 clonal cells transfected with either scrambled shRNA (NC-3) or anti-IDO shRNA (2–18) were tr...
<p>In varying ratios, B6.<i>lpr</i>.IFNγR<sup>−/−</sup> or B6.<i>lpr</i>.IFNγR<sup>+/+</sup> DN T ce...
<p><i>(</i><i>a</i><i>),</i> An example of IDO5-specific, CD8 T-cell enriched PBMC from a renal cell...
<p>(<b>A</b>) Representative HPLC graphs of kyn production of HeLa cells, which were either untreate...
<p><i>(</i><i>a</i><i>),</i> Lysis by the IDO5-specific T-cell clone (RBS35) of the HLA-A2<sup>+</su...
<p>MDA-MB-231 clone 10A (MDA-231 c10A), VC5 (MDA-231 c10A, transfected with the empty plasmid vector...
<p>Proliferation of each of 5 individual A549 cell clonal populations before <b>(Panel A and C)</b> ...
Triple-negative breast cancer (TNBC) escape from immune-mediated destruction was associated with imm...
<p>Interfering with the IFNγ pathway in MSCs can partially restore Vδ2+ cell proliferation (A) Compa...
<p><i>(</i><i>a</i><i>)</i>, <i>Left:</i> Lysis of autologous <i>in vitro</i> immatured and matured ...
<p><i>(</i><i>a</i><i>),</i> Lysis of T2-cells pulsed with IDO5 peptide or an irrelevant peptide (th...
<p>(A) Lentiviral-mediated shRNA transduction of MSCs was used to knock down IDO (MSC-IDOi). Quantif...
<p>A549 cells were transfected with control or anti-thymidylate synthase (anti-TS) siRNA, treated wi...
<p>A549 cells were transfected with scrambled, non-targeting control siRNA or anti-thymidylate synth...
<p>PBMC from healthy donors, breast cancer patients, melanoma patients, and renal cell carcinoma pat...
<p>A549 clonal cells transfected with either scrambled shRNA (NC-3) or anti-IDO shRNA (2–18) were tr...
<p>In varying ratios, B6.<i>lpr</i>.IFNγR<sup>−/−</sup> or B6.<i>lpr</i>.IFNγR<sup>+/+</sup> DN T ce...
<p><i>(</i><i>a</i><i>),</i> An example of IDO5-specific, CD8 T-cell enriched PBMC from a renal cell...
<p>(<b>A</b>) Representative HPLC graphs of kyn production of HeLa cells, which were either untreate...
<p><i>(</i><i>a</i><i>),</i> Lysis by the IDO5-specific T-cell clone (RBS35) of the HLA-A2<sup>+</su...
<p>MDA-MB-231 clone 10A (MDA-231 c10A), VC5 (MDA-231 c10A, transfected with the empty plasmid vector...
<p>Proliferation of each of 5 individual A549 cell clonal populations before <b>(Panel A and C)</b> ...
Triple-negative breast cancer (TNBC) escape from immune-mediated destruction was associated with imm...
<p>Interfering with the IFNγ pathway in MSCs can partially restore Vδ2+ cell proliferation (A) Compa...